Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
Clinical trial NCT05526989 · RECRUITING
Trial details
- NCT number
- NCT05526989
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-28
- Primary completion
- 2026-11-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.